Xanthohumol and Viral Infections (XL)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Vienna

About this trial

The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.

Eligibility criteria

Qualifiers

healthy

BMI >18 kg/m² or < 28kg/m²

Disqualifiers

food intolerances

food allergies

chronic inflammatory diseases

metabolic diseases

Trial design

Treatments tested in this trial

  • Xanthohumol
  • Placebo

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators